This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Commission Remove Financial Guidance Remove Pharmaceutical Related Topics
Financial Consultant Certified Financial Planner Investment Planning Ethics Fee Only Wealth Advisor Financial Advice License Investment Advisor Portfolio Management More Related Topics >
article thumbnail

Should the CFP Board police financial advisor “bad apples”? The debate continues! (Part Two)

Sara Grillo

SEPTEMBER 26, 2022

So that’s fundamentally different, and it makes it harder for us to become a profession that it is, I think for those self-governing bodies… Wright: Well, I guess the only caveat to medicine is when you get into pharmaceuticals. Securities and Exchange Commission. Securities and Exchange Commission. 2022, August 1).

CFP 59
CFP Financial Advisor Financial Planner Ethics 59
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 74,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024